Deep in your nervous system lives a small molecule called CGRP (calcitonin gene-related peptide). In normal circumstances, CGRP helps regulate blood vessel diameter and inflammation. But in migraine sufferers, CGRP goes haywire.
When a migraine attack is triggered (by stress, hormones, certain foods, or sometimes nothing obvious), your neurons release massive amounts of CGRP. This causes blood vessels to dilate dramatically, triggers intense inflammation in the meninges (brain membranes), and sensitizes pain pathways so that normal sensations feel excruciating. Your brain becomes a pain amplification machine.
Tradditional painkillers work by blocking pain signals after they've already been sent. But CGRP-targeting peptides work differently - they prevent the cascade from starting in the first place.
"Prevention is infinitely better than treating a migraine attack that's already underway."
This is why the discovery of CGRP-targeting therapies represents a quantum leap in migraine treatment. For the first time, we can actually target the root mechanism instead of just damaging painkillers after the fact.